Why Celldex Shares Are Falling: Drug Trial Safety Concerns & Market Impact
Celldex shares plummeted 15% as clinical trial safety concerns clouded an experimental skin drug win. Read equity analysis, investor risks, and market impact.
Celldex shares plummeted 15% as clinical trial safety concerns clouded an experimental skin drug win. Read equity analysis, investor risks, and market impact.
Hindustan Copper shares gain 3% following a ₹7,000 crore 5-year capital investment plan, strategic PSU MoUs, and CODELCO partnership.
Dalmia Bharat Refractories offloads an 11.11% stake in RHI Magnesita India via an ₹826 crore block deal at ₹360 per share, led by SBI Mutual Fund.
Hillhouse-backed Elevate Campuses secures ₹945 crore from 20 anchor investors ahead of its ₹2,100 crore IPO. Read valuation and risk analysis.
Jindal Supreme IPO finalized its basis of allotment following a massive 362.14x subscription. Check allotment status on BSE, NSE, and registrar platforms.
Sai Urja Indo Ventures IPO opens for subscription as part of a major ₹4,169 crore primary market rush. Explore valuation multiples, peer benchmarks, and GMP trends.
SEBI unveils streamlined digital onboarding and wider FPI access in commodity derivatives, aiming to bolster foreign institutional participation.
Varmora Granito's ₹708-crore IPO opened on September 22, 2026, priced at ₹140–148 per share. Explore anchor allocation, valuation benchmarks & broker insights.
Karamtara Engineering prepares for a ₹875 crore IPO with top legal advisors CAM, Trilegal, and A&O Shearman — valuation audit, growth catalysts, and risk analysis.
Sunil Singhania-led Abakkus Asset Manager files draft IPO papers with SEBI for a 10% equity OFS. Sector analysis, peer benchmarks, and AUM milestones.